Cincinnati, Ohio
CNS trials open to children and teens in Cincinnati, OH
34 CNS studies open to children and teens are recruiting participants at sites in Cincinnati as of November 18, 2026, according to ClinicalTrials.gov. CNS Pediatric Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Cincinnati at a glance
- 34 studies are recruiting at a site in Cincinnati.
- By phase: Phase 1 (1), Phase 3 (15), Phase 4 (6), No phase (9), Observational (3). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (19), university, hospital or other (15).
- By research area: Migraine (13), ADHD (8), Depression (5), Schizophrenia (5), Epilepsy (2), Bipolar Disorder (1).
- Most recent update to one of these records: November 13, 2026.
ADHD studies recruiting in Cincinnati
Basic details from each study's public record (the 30 most recently updated of 34). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
AWARE: Management of ADHD in Autism Spectrum Disorder
- Phase 4
- Ages 4 to 17
- All sexes
- Sponsor
- Daniel Coury
- Study site
- Cincinnati Children's Hospital Medical Center
- Registry record
- NCT05916339 · updated
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- Phase 4
- From 48 months, up to 69 months
- All sexes
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Study site
- Cincinnati Children's Hospital and Medical Center
- Registry record
- NCT04781140 · updated
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
- Phase 4
- Ages 8 to 12
- All sexes
- Sponsor
- Donald Gilbert, MD, MS, FAAN, FAAP
- Study site
- Cincinnati Children's Hospital Medical Center
- Registry record
- NCT04421248 · updated
Treating Young Children With Attention Deficit Hyperactivity Disorder
- Phase 4
- Ages 3 to 5
- All sexes
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Study site
- Cincinnati Children's Hospital Medical Center
- Registry record
- NCT07300956 · updated
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Observational
- Ages 0 to 20
- All sexes
- Sponsor
- Duke University
- Study site
- Cincinnati Childrens Hospital Medical Center
- Registry record
- NCT04278404 · updated
Impact of Short and Mistimed Sleep on Adolescents With ADHD: The Adolescent Attention and Circadian Timing Study
- No phase
- Ages 13 to 17
- All sexes
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Study site
- Cincinnati Children's Hospital Medical Center
- Registry record
- NCT07684417 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Cincinnati, OH on ClinicalTrials.gov.
Depression studies recruiting in Cincinnati
Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
- No phase
- Ages 12 to 22
- All sexes
- Sponsor
- Michigan State University
- Study site
- Cincinnati Children's Hospital Medical Center
- Registry record
- NCT06232304 · updated
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- Phase 3
- Ages 10 to 17
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study site
- University of Cincinnati Medical Center
- Registry record
- NCT06372964 · updated
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
- Observational
- From 18 months, up to 11 years
- All sexes
- Sponsor
- State University of New York at Buffalo
- Study site
- Cincinnati Children's Hospital Medical Center
- Registry record
- NCT07048574 · updated
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- University of Cincinnati
- Registry record
- NCT07227454 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Cincinnati, OH on ClinicalTrials.gov.
Epilepsy studies recruiting in Cincinnati
A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
- Phase 3
- From 1 day, up to 18 years
- All sexes
- Sponsor
- Praxis Precision Medicines
- Study site
- Praxis Research Site
- Registry record
- NCT07019922 · updated
Epilepsy Journey-An Executive Functioning Intervention for Teens With Epilepsy
- No phase
- Ages 13 to 17
- All sexes
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Study site
- Cincinnati Children's Hospital Medical Center
- Registry record
- NCT06608966 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Cincinnati, OH on ClinicalTrials.gov.
Migraine studies recruiting in Cincinnati
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study site
- Cincinnati Children's Hospital Medical Center
- Registry record
- NCT04649242 · updated
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study site
- Cincinnati Children's Hospital
- Registry record
- NCT04743141 · updated
Overlapping Pain Trajectory Study
- Observational
- Ages 10 to 19
- All sexes
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Study site
- Cincinnati Children's Hospital
- Registry record
- NCT05752396 · updated
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- H. Lundbeck A/S
- Study site
- Cincinnati Children's Hospital Medical Center-Burnet Campus
- Registry record
- NCT04965675 · updated
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study site
- Cincinnati Children's Hospital Medical Center
- Registry record
- NCT05156398 · updated
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- H. Lundbeck A/S
- Study site
- Cincinnati Children's Hospital Medical Center-Burnet Campus
- Registry record
- NCT05164172 · updated
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- H. Lundbeck A/S
- Study site
- Cincinnati Children's Hospital Medical Center-Burnet Campus
- Registry record
- NCT05897320 · updated
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- AbbVie
- Study sites
- Cincinnati Childrens Hospital Medical Center /ID# 258070 · Patient Priority Clinical Sites, LLC /ID# 247535
- Registry record
- NCT05711394 · updated
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Phase 1
- Ages 6 to 11
- All sexes
- Sponsor
- Pfizer
- Study site
- Cincinnati Children's Hospital Medical Center
- Registry record
- NCT06995729 · updated
Responding With Evidence and Access for Childhood Headaches
- No phase
- Ages 10 to 17
- All sexes
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Study site
- Cincinnati Children's Hospital Medical Center
- Registry record
- NCT05889624 · updated
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- AbbVie
- Study sites
- Cincinnati Childrens Hospital Medical Center /ID# 244689 · Headache Center of Hope /ID# 242645 · Patient Priority Clinical Sites, LLC /ID# 238485
- Registry record
- NCT05125302 · updated
Supraspinal Processing of Sensory Aspects of Pain
- No phase
- Ages 10 to 17
- All sexes
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Study site
- Cincinnati Children's Hospital
- Registry record
- NCT05814497 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Cincinnati, OH on ClinicalTrials.gov.
Schizophrenia studies recruiting in Cincinnati
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- Phase 3
- Ages 13 to 17
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- University of Cincinnati Dept of Psychiatry and Behavioral Neuroscience
- Registry record
- NCT07288567 · updated
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Phase 3
- Ages 5 to 17
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Study site
- University of Cincinnati Cancer Institute
- Registry record
- NCT07424404 · updated
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Phase 3
- Ages 5 to 17
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study site
- University of Cincinnati Medical Center
- Registry record
- NCT06229210 · updated
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
- Phase 4
- Ages 12 to 17
- All sexes
- Sponsor
- Vanda Pharmaceuticals
- Study site
- Vanda Investigational Site
- Registry record
- NCT05648591 · updated
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Phase 3
- Ages 10 to 17
- All sexes
- Sponsor
- Alkermes, Inc.
- Study site
- Alkermes Investigator Site
- Registry record
- NCT05303064 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Cincinnati, OH on ClinicalTrials.gov.
Bipolar disorder studies recruiting in Cincinnati
Child Bipolar Network Ketogenic Diet Approach to Bipolar Disorder in Adolescents
- No phase
- Ages 12 to 21
- All sexes
- Sponsor
- University of California, Los Angeles
- Study site
- University of Cincinnati College of Medicine
- Registry record
- NCT06920940 · updated
Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in Cincinnati, OH on ClinicalTrials.gov.
Ask about studies near Cincinnati
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Ohio
All Ohio locations
40 studies recruiting across 7 cities.
Columbus
7 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that set an upper age limit, with at least half of the ages they accept under 18, as each study is coded in the registry.
CNS Pediatric Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections